Aptamer-Conjugated Apigenin Nanoparticles To Target Colorectal Carcinoma: A Promising Safe Alternative of Colorectal Cancer Chemotherapy
- 16 October 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 1 (5) , 1538-1556
Abstract
Apigenin has gained interest recently among researchers as a potential chemotherapeutic agent in cancer, including colorectal cancer, due to its established antiproliferative activity in vitro. Despite its impressive anticancer activity in vitro, poor water solubility and nonspecific distribution in vivo make it difficult for its emergence as a drug candidate. To overcome the problems, we formulated aptamer-conjugated apigenin-loaded nanoparticle (apt-ANP) to target against Epithelial Cell Adhesion Molecule (EpCAM), overexpressed as a surface biomarker of colorectal cancer cells. Aptamer-conjugation was conducted on the prepared nanoparticle, characterized (by SEM, TEM and AFM) and evaluated for its antiproliferative activity towards in vitro colon carcinoma cells and in vivo colorectal cancer model. The aptamer-conjugated nanoformulation had an average size about 226 nm, smooth surface, 17.5±1.3% drug loading and a sustained drug release profile. Pharmacokinetic and biodistribution data demonstrated an enhanced retention time of apt-ANP in colon as compared to free-drug and aptamer-free apigenin-loaded nanoparticle (ANP). Apt-ANP enhanced therapeutic efficacy to colorectal cancer cells whereas minimized off-target cytotoxicity to normal cells.Keywords
Funding Information
- Department of Biotechnology , Ministry of Science and Technology
This publication has 52 references indexed in Scilit:
- Apigenin affects leptin/leptin receptor pathway and induces cell apoptosis in lung adenocarcinoma cell lineEuropean Journal of Cancer, 2011
- Molecular targets of apigenin in colorectal cancer cells: Involvement of p21, NAG-1 and p53European Journal of Cancer, 2010
- Flavonoids, Proanthocyanidins, and Cancer Risk: A Network of Case-Control Studies From ItalyNutrition and Cancer, 2010
- Apigenin: A Promising Molecule for Cancer PreventionPharmaceutical Research, 2010
- Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProceedings of the National Academy of Sciences, 2006
- Glutathione is required for growth and prespore cell differentiation in DictyosteliumDevelopmental Biology, 2005
- PHARMACOKINETICS AND METABOLISM OF APIGENIN IN FEMALE AND MALE RATS AFTER A SINGLE ORAL ADMINISTRATIONDrug Metabolism and Disposition, 2005
- Selective Growth-Inhibitory, Cell-Cycle Deregulatory and Apoptotic Response of Apigenin in Normal versus Human Prostate Carcinoma CellsBiochemical and Biophysical Research Communications, 2001
- Glutathione Redox Potential Modulated by Reactive Oxygen Species Regulates Translation of Rubisco Large Subunit in the ChloroplastJournal of Biological Chemistry, 2000
- The evidence from infrared spectroscopy for hydrogen bonding: A case history of the correlation and interpretation of dataJournal of Chemical Education, 1957